Study Linking Cell Phone Use to Cancer Stirs Debate

Exposing male rats to nonionizing radiation increased the animals’ risk of brain and heart tumors in a study, but the findings are far from conclusive.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Sprague Dawley ratFLICKR, JEAN-ETIENNE MINH-DUY POIRRIERPartial results from a large-scale, peer-reviewed study conducted by scientists at the US National Toxicology Program (NTP) on the effects of cell phone-frequency radiation on rats and mice were released yesterday (May 26) on the preprint server bioRxiv. The NTP team found a 2.2 percent to 3.3 percent higher incidence of malignant gliomas in the brains and schwannomas in the hearts of male rats exposed to the radiation. But reviewers of the study and other scientists raised a number of important caveats.

“This is a controlled study and seems to have a solid study design,” Jill Barnholtz-Sloan of Case Western Reserve University School of Medicine, who was not involved in the study, wrote in an email to The Scientist. However, “there is not a clear dose response relationship from these data,” Barnholtz-Sloan said. “I also question the statistical power that they had to see these very small differences in incidence based on their sample size.”

NTP researchers exposed Sprague Dawley rats to 900 Megahertz GSM or CDMA radiofrequency radiation for nine hours a day throughout their lives, beginning in utero, at doses of 1.5, 3, or 6 Watts per kilogram (W/kg). (The US Federal Communications Commission limit for cellphone exposure in humans is 1.6 W/kg.) Each group ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies